Impact of elexacaftor/tezacaftor/ivacaftor on glucose tolerance in adolescents with cystic fibrosis.
Galderisi A, Weiss L, Besançon A, Stremler N, Reix P, Wizla N, Lustre A, Rames C, Tatopoulos A, Perisson C, Dalphin ML, Troussier F, Houdouin V, Bessaci K, Cosson L, Gabsi A, Corvol H, Deneuville E, Storni V, Ramel S, Bui S, Heraud MC, Remus N, Huet F, Scalbert M, Mely L, Gachelin E, Giannantonio M, Letierce A, Sahki D, Marguet C, Bonnel AS, Sermet-Gaudelus I; MODUL CF group.
Galderisi A, et al. Among authors: scalbert m.
J Clin Endocrinol Metab. 2025 Feb 20:dgaf099. doi: 10.1210/clinem/dgaf099. Online ahead of print.
J Clin Endocrinol Metab. 2025.
PMID: 39977216